Professor Mei Yanchang, Executive Vice President of the National University of Singapore, and his delegation visited Yinfeng Biotech Group
Release time:
2019-05-13
On May 13th, Professor Mei Yanchang, Executive Vice President and Assistant Vice President of the National University of Singapore, Li Yaoming, Deputy Director of the Jinan Science and Technology Bureau, Liu Dezhi, Member of the Party Working Committee of the Jinan High tech Zone Management Committee and Deputy Director of the National Information and Communication International Innovation Park Management Committee, Li Shixin, Deputy Director of the High tech Zone Management Committee, Huang Bo, and Deputy Director of the High tech Zone Entrepreneurship Service Center, Wang Yan, were elected, Li Shucai, Vice President of Shandong University, and a delegation of 15 people visited Yinfeng Biotechnology Group, accompanied by Ma Xiaoqing, Chairman of Shandong Qilu Stem Cell Engineering Co., Ltd., and Liu Guojun, President.
Mei Yanchang and his delegation visited the stem cell storage and low-temperature medicine laboratory under Yinfeng Biotechnology Group, and carefully listened to the achievements of Yinfeng Biotechnology Group in scientific and technological innovation and transformation in the field of biomedicine. Subsequently, Qilu Stem Cells and Yinfeng Low Temperature Medicine Company, as representatives of enterprises in the biopharmaceutical field, participated in a symposium hosted by Wang Hongzhi, a member of the Standing Committee of the Jinan Municipal Party Committee and Director of the High tech Zone Management Committee, with the theme of "Cross border Cooperation between Chinese Universities and Enterprises".
Professor Mei Yanchang deeply recognizes the storage capacity and application of Yinfeng Biotechnology Group in the field of stem cells. Meanwhile, He said: Yinfeng Biotechnology Group breaks through barriers in the field of deep and low-temperature preservation, adheres to independent scientific research and innovation, and leads the international research results. The National University of Singapore aims to promote innovation and development of healthcare products through interdisciplinary cooperation in the fields of chemistry, biology, physics, engineering, science, and medicine in the field of cell biology, in order to meet the needs of the global and Singapore markets. During this visit, our university learned about Shandong and Jinan in China The remarkable achievements of enterprises in the field of biotechnology in the field of biomedicine have provided important resources and support for the future joint construction of the 'SDU-NUS Biomedical Engineering International Joint Research Institute (Jinan)' project between our university and Shandong University, strengthening the multi-party cooperation model among schools, enterprises, and hospitals, and promoting the construction of scientific research platforms and the transformation of achievements
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
